News ACCORDION CV Mortality Drops, Eye Benefits Remain in Follow-up by Medscape • 2015/12/09 • 0 Comments New data from ACCORD long-term follow-up study: cardiovascular mortality risk with tight glycemic control attenuates, retinopathy benefit remains, and brain function unaffected. Medscape Medical News Full Story →